KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Change in Taxes: 2016-2021

Historic Change in Taxes for BeOne Medicines (ONC) over the last 5 years, with Mar 2021 value amounting to $7.1 million.

  • BeOne Medicines' Change in Taxes rose 17.58% to $7.1 million in Q1 2021 from the same period last year, while for Mar 2021 it was $3.4 million, marking a year-over-year decrease of 73.27%. This contributed to the annual value of $2.3 million for FY2020, which is 69.35% down from last year.
  • BeOne Medicines' Change in Taxes amounted to $7.1 million in Q1 2021, which was down 51.00% from $14.6 million recorded in Q4 2020.
  • In the past 5 years, BeOne Medicines' Change in Taxes ranged from a high of $14.6 million in Q4 2020 and a low of -$9.3 million during Q3 2020.
  • In the last 3 years, BeOne Medicines' Change in Taxes had a median value of $4.4 million in 2019 and averaged $1.9 million.
  • Its Change in Taxes has fluctuated over the past 5 years, first spiked by 5,251.52% in 2017, then tumbled by 1,730.22% in 2018.
  • Quarterly analysis of 5 years shows BeOne Medicines' Change in Taxes stood at $6.3 million in 2017, then slumped by 32.55% to $4.3 million in 2018, then climbed by 3.32% to $4.4 million in 2019, then skyrocketed by 232.14% to $14.6 million in 2020, then increased by 17.58% to $7.1 million in 2021.
  • Its last three reported values are $7.1 million in Q1 2021, $14.6 million for Q4 2020, and -$9.3 million during Q3 2020.